Fred Alger Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.6M Buy
125,766
+44,455
+55% +$6.83M 0.09% 111
2025
Q4
$14.2M Sell
81,311
-12,722
-14% -$2.32M 0.06% 145
2025
Q3
$13.5M Sell
94,033
-95,686
-50% -$11.7M 0.05% 159
2025
Q2
$19.1M Sell
189,719
-188,612
-50% -$14.4M 0.09% 123
2025
Q1
$28.9M Sell
378,331
-7,129
-2% -$545K 0.16% 85
2024
Q4
$26.6M Sell
385,460
-66,856
-15% -$4.81M 0.13% 110
2024
Q3
$33M Sell
452,316
-46,256
-9% -$3.41M 0.16% 100
2024
Q2
$33.4M Buy
+498,572
New +$19.3M 0.16% 96
2019
Q3
Sell
-13,000
Closed -$333K 517
2019
Q2
$333K Buy
+13,000
New +$362K ﹤0.01% 393

Other funds holding INSM

Fred Alger Management's INSM Position: Q1 2026 in Review

Fred Alger Management increased its Insmed (INSM) stake by 55% in Q1 2026, buying an estimated $6.83M and bringing the position to 125,766 shares worth $20.6M. The position accounts for 0.09% of the portfolio, ranked #111.

Fred Alger Management first reported a position in INSM in Q2 2019 and has held it in 9 quarters since. The position peaked at $33.4M in Q2 2024. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Fred Alger Management held 125,766 shares of Insmed worth $20.6M as of Q1 2026.
  • Fred Alger Management bought 44,455 Insmed shares in Q1 2026, an estimated $6.83M.
  • Insmed made up 0.09% of Fred Alger Management's portfolio in Q1 2026, its #111 holding.
  • Fred Alger Management first reported a position in Insmed in Q2 2019 and has held it in 9 quarters since.
  • Fred Alger Management's Insmed position peaked at $33.4M in Q2 2024.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.